Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
about
The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisRecent advances in multidisciplinary management of hepatocellular carcinomaThrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysisSeverity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinomaTreatment algorithms for managing hepatocellular carcinomaPretreatment platelet count early predicts extrahepatic metastasis of human hepatoma.Favorable effect of thrombocytopenia on outcomes of liver transplantation for hepatocellular carcinoma.Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.Comparison of liver resection and transplantation for Child-pugh A cirrhotic patient with very early hepatocellular carcinoma and portal hypertension.Hepatocellular carcinoma: clinical frontiers and perspectives.Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus.Prognostic significance of preoperative platelet count in patients with gallbladder cancer.Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissuesMicrovascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinomaMicrovascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors.The preoperative alkaline phosphatase-to-platelet ratio index is an independent prognostic factor for hepatocellular carcinoma after hepatic resection.Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.Propensity score analysis demonstrated the prognostic advantage of anatomical liver resection in hepatocellular carcinoma.Treatment of hepatocellular carcinoma: a systematic review.Treatment strategy to improve long-term survival for hepatocellular carcinoma smaller than 5 cm: major hepatectomy vs minor hepatectomy.Hepatocellular carcinoma: a comprehensive overview of surgical therapy.Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size.Curative therapies for hepatocellular carcinoma: an update and perspectives.Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma.Yes-associated protein (YAP) expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma.Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalitiesHepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA.Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.Anatomical versus non-anatomical liver resection for hepatocellular carcinoma exceeding Milan criteria.Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection.Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria.Shall we take a second thought before applying radiofrequency ablation for resectable HCC ≤2 cm?Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma.The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma.
P2860
Q26786170-AC8E09C8-5CA2-456E-A886-7EC8FE055C23Q26863748-7A348C73-7FEC-4C83-91D8-39A152816468Q26998730-18ACE2A5-F24D-4250-A6AA-28A5BBD4A7CDQ27013963-42094965-795C-4FEC-83A3-1F34C57E2D8DQ27027923-1546139F-833F-4A56-B58C-213E44F498F0Q33420986-F1814F27-76D3-4B89-9D7E-2E077EEC0806Q33429335-7F0CE7F2-D38C-4CCC-A58E-85300DE95159Q34067936-1F39D02A-95D9-4D93-92A7-31362B48DF1BQ34176160-418C62F3-685E-455A-8EAB-5330DC7CD79CQ35112053-28ABCC95-6D2A-4774-8C51-261F9F12725AQ35169362-874791D7-622D-4E8E-B0B2-C39B6954714CQ35469039-827588B6-7587-4183-89BD-9D96B649A55CQ35567661-D0F4BD33-B0D6-40F8-B32D-F694786DCFABQ35594262-4BAB7D5C-B29B-462C-8C9D-F12412C7F67CQ35776681-6C47C052-2E5C-4AB8-ADC1-DD8A32D1E631Q36251812-D3369091-6603-4772-80EB-66FA1334B172Q36285621-01B27191-63EB-4A1E-9C63-6F3E5F0795F4Q37031706-6546FDF9-6C47-4D09-8557-88E5D9E6DC30Q37375773-4CC9AA3E-29D1-4AC4-B652-5B581E9E9A8BQ37530615-7C9EB55D-11BE-4647-848F-738207752058Q37593560-2950C9F1-CD35-4388-BE26-E9FC7AD07DB8Q37619833-FED50F2F-00CF-4C50-9B93-1A09353A5938Q37660712-C3C38963-7F55-43A5-8839-80EBC720E26CQ38155508-7DB0ECE9-D9D7-47F7-9298-A75FDB3E5C5CQ38212000-40B5B056-93D1-4795-8766-BE5AC1835A07Q38217436-F0101169-7645-4549-9853-32EC566463CCQ38255701-05A4B572-985C-449D-8B5E-2C12CCE6174BQ38640531-610F23B6-091B-4C22-BB50-25D4730EADB6Q38671883-B3614382-8ECA-4A97-AA4E-2B832A3C6020Q38719022-34B8FBA2-A293-49EA-A182-4BBA67EA4854Q38845349-DE9077F5-4F73-4EAE-8182-7272331029E5Q38935703-3C4DFAD2-6972-4962-8590-9976FCF785F0Q38962965-454D8EB9-58C9-4756-809C-123D3E9095F5Q39179820-45DEBB03-DC56-4958-B4FD-FF435D5FCDEAQ39328649-81BE6FC8-41C6-48D6-9B84-214E540E491CQ39473320-6671657B-DD9B-4EA1-BEA9-D45F370CC654Q40968769-A3BB738D-13A8-480F-84B8-4CDDE48A91C0Q41351137-BD232CD7-4FA1-4375-A880-7863F84CB1DEQ41506663-3E17B4ED-CAD4-4C47-8C86-4543E9D85862Q41736718-2C36AD2D-89A0-41FB-B1E7-038C7B97BCF5
P2860
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
@ast
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
@en
type
label
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
@ast
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
@en
prefLabel
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
@ast
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
@en
P2093
P2860
P50
P356
P1433
P1476
Resection of hepatocellular cancer ≤2 cm: results from two Western centers
@en
P2093
Daniel Labow
Khaled Obeidat
Myron Schwartz
Sasan Roayaie
P2860
P304
P356
10.1002/HEP.25832
P407
P50
P577
2013-01-25T00:00:00Z